Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 CAD | +9.09% | -17.24% | +50.00% |
03-26 | Marvel Biosciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
03-25 | Marvel Biosciences Announces Positive Interim Results For MB-204 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+50.00% | 3.2M | |
+29.05% | 48.16B | |
-0.67% | 41.73B | |
+44.64% | 41.03B | |
-5.31% | 28.77B | |
+10.48% | 25.59B | |
-22.47% | 18.96B | |
+8.50% | 12.92B | |
+28.68% | 12.03B | |
-2.57% | 11.77B |
- Stock Market
- Equities
- MRVL Stock
- News Marvel Biosciences Corp.
- Marvel Biosciences : up 8.7% as Provides Update on Lead Candidate MB-204 Manufacturing